Skip to main content
Erschienen in: American Journal of Clinical Dermatology 1/2003

01.01.2003 | Therapy in Practice

Recognition and Management of the Cutaneous Manifestations of Celiac Disease

A Guide for Dermatologists

verfasst von: Dr Pekka Collin, Timo Reunala

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 1/2003

Einloggen, um Zugang zu erhalten

Abstract

In celiac disease, the ingestion of gluten-containing cereals, such as wheat, rye, and barley, results in small-bowel mucosal inflammation and villous atrophy with crypt hyperplasia. The prevalence of the condition may be as high as 1% in the adult population. The disease can also embrace various extraintestinal manifestations, of which dermatitis herpetiformis is the best known. Earlier, dermatitis herpetiformis was considered a skin disease occurring often concomitantly with celiac disease. At present, a body of evidence shows that dermatitis herpetiformis is a cutaneous manifestation of celiac disease, and affects approximately 25% of patients with celiac disease. Both conditions can appear in the same family and are closely linked to HLA class II locus in chromosome 6; 90% of patients have HLA DQ2 and, almost all the remainder, HLA DQ8. All patients with dermatitis herpetiformis have at least some-degree of mucosal inflammation or lesion consistent with celiac disease. The etiology of celiac disease in not fully understood, but tissue transglutaminase seems to be the predominant autoantigen both in the intestine and the skin. Serum antibodies against tissue transglutaminase can be used in the serologic screening and follow-up of dietary compliance of patients with celiac disease. Gluten-free diet is essential in the treatment of both conditions, and oral dapsone is usually needed in newly detected dermatitis herpetiformis in order to alleviate symptoms. Oral mucosal lesions, alopecia areata, and vitiligo probably occur more frequently in patients with dermatitis herpetiformis than in the general population. By contrast, the reported association of celiac disease with psoriasis seems to be coincidental.
Literatur
1.
Zurück zum Zitat Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120: 636–651PubMedCrossRef Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120: 636–651PubMedCrossRef
2.
Zurück zum Zitat Moi H. Incidence and prevalence of dermatitis herpetiformis in a county in central Sweden with comments on the course of the disease and IgA deposits as a diagnostic criterion. Acta Derm Venereol 1984; 64: 144–150PubMed Moi H. Incidence and prevalence of dermatitis herpetiformis in a county in central Sweden with comments on the course of the disease and IgA deposits as a diagnostic criterion. Acta Derm Venereol 1984; 64: 144–150PubMed
3.
Zurück zum Zitat Gawkrodger D.J.G., Blackwell J.N., Gilmour H.K., et al. Dermatitis herpetiformis, diagnosis, diet and demography. Gut 1984; 25: 151–157PubMedCrossRef Gawkrodger D.J.G., Blackwell J.N., Gilmour H.K., et al. Dermatitis herpetiformis, diagnosis, diet and demography. Gut 1984; 25: 151–157PubMedCrossRef
4.
Zurück zum Zitat Egan C.A., O’Loughlin S., Gormally P., et al. Dermatitis herpetiformis: a review of fifty-four patients. Ir J Med Sci 1997; 166: 241–244PubMedCrossRef Egan C.A., O’Loughlin S., Gormally P., et al. Dermatitis herpetiformis: a review of fifty-four patients. Ir J Med Sci 1997; 166: 241–244PubMedCrossRef
5.
Zurück zum Zitat Sigurgeirsson B., Agnarsson B.A., Lindelöf B. Risk of lymphoma in patients with dermatitis herpetiformis. BMJ 1994; 308: 13–15PubMedCrossRef Sigurgeirsson B., Agnarsson B.A., Lindelöf B. Risk of lymphoma in patients with dermatitis herpetiformis. BMJ 1994; 308: 13–15PubMedCrossRef
6.
Zurück zum Zitat Collin P., Reunala T., Rasmussen M., et al. High incidence and prevalence of adult coeliac disease: augmented diagnostic approach. Scand J Gastroenterol 1997; 32: 1129–1133PubMedCrossRef Collin P., Reunala T., Rasmussen M., et al. High incidence and prevalence of adult coeliac disease: augmented diagnostic approach. Scand J Gastroenterol 1997; 32: 1129–1133PubMedCrossRef
7.
Zurück zum Zitat Hall R.P., Clark R.E., Ward F.E. Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics. J Am Acad Dermatol 1990; 22: 436–439PubMedCrossRef Hall R.P., Clark R.E., Ward F.E. Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics. J Am Acad Dermatol 1990; 22: 436–439PubMedCrossRef
8.
Zurück zum Zitat Shibahara M., Nanko H., Shimizu M., et al. Dermatis herpetiformis in Japan: an update. Dermatology 2002; 204: 37–42PubMedCrossRef Shibahara M., Nanko H., Shimizu M., et al. Dermatis herpetiformis in Japan: an update. Dermatology 2002; 204: 37–42PubMedCrossRef
9.
Zurück zum Zitat Karpati S., Kosnai I., Verkasalo M., et al. HLA antigens, jejunal morphology and associated diseases in children with dermatitis herpetiformis. Acta Paediatr Scand 1986; 75: 297–301PubMedCrossRef Karpati S., Kosnai I., Verkasalo M., et al. HLA antigens, jejunal morphology and associated diseases in children with dermatitis herpetiformis. Acta Paediatr Scand 1986; 75: 297–301PubMedCrossRef
10.
Zurück zum Zitat Ermacora E., Prampolini L., Tribbia G., et al. Long-term follow-up of dermatitis herpetiformis children. J Am Acad Dermatol 1986; 15: 24–30PubMedCrossRef Ermacora E., Prampolini L., Tribbia G., et al. Long-term follow-up of dermatitis herpetiformis children. J Am Acad Dermatol 1986; 15: 24–30PubMedCrossRef
12.
Zurück zum Zitat Hervonen K., Hakanen M., Kaukinen K., et al. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol 2002; 37: 51–55PubMedCrossRef Hervonen K., Hakanen M., Kaukinen K., et al. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol 2002; 37: 51–55PubMedCrossRef
13.
Zurück zum Zitat Meyer L.J., Zone J.J. Familial incidence of dermatitis herpetiformis. J Am Acad Dermatol 1987; 17: 643–647PubMedCrossRef Meyer L.J., Zone J.J. Familial incidence of dermatitis herpetiformis. J Am Acad Dermatol 1987; 17: 643–647PubMedCrossRef
14.
Zurück zum Zitat Lähteenoja H., Irjala K., Viander M., et al. Oral mucosa is frequently affected in patients with dermatitis herpetiformis. Arch Dermatol 1998; 134: 756–758PubMedCrossRef Lähteenoja H., Irjala K., Viander M., et al. Oral mucosa is frequently affected in patients with dermatitis herpetiformis. Arch Dermatol 1998; 134: 756–758PubMedCrossRef
15.
Zurück zum Zitat Patinen P., Hietanen J., Malmström M., et al. Iodine and gliadin challenge on oral mucosa in dermatitis herpetiformis. Acta Derm Venereol 2002; 82: 86–89PubMedCrossRef Patinen P., Hietanen J., Malmström M., et al. Iodine and gliadin challenge on oral mucosa in dermatitis herpetiformis. Acta Derm Venereol 2002; 82: 86–89PubMedCrossRef
16.
Zurück zum Zitat van der Meer R. Granular deposits of immunoglobulins in the skin of the patients with dermatitis herpetiformis. Br J Dermatol 1969; 81: 493–503PubMedCrossRef van der Meer R. Granular deposits of immunoglobulins in the skin of the patients with dermatitis herpetiformis. Br J Dermatol 1969; 81: 493–503PubMedCrossRef
17.
Zurück zum Zitat Zone J.J., Meyer L.J., Petersen M.J. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol 1996; 132: 912–918PubMedCrossRef Zone J.J., Meyer L.J., Petersen M.J. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol 1996; 132: 912–918PubMedCrossRef
18.
Zurück zum Zitat Beutner E.H., Chorzelski T.B., Reunala T.L., et al. Immunopathology of dermatitis herpetiformis. Clin Dermatol 1992; 9: 295–311CrossRef Beutner E.H., Chorzelski T.B., Reunala T.L., et al. Immunopathology of dermatitis herpetiformis. Clin Dermatol 1992; 9: 295–311CrossRef
19.
Zurück zum Zitat Guide S.V., Marinkovich M.P. Linear IgA bullous dermatosis. Clin Dermatol 2001; 19: 719–727PubMedCrossRef Guide S.V., Marinkovich M.P. Linear IgA bullous dermatosis. Clin Dermatol 2001; 19: 719–727PubMedCrossRef
20.
Zurück zum Zitat Alexander J.O. Dermatitis herpetiformis: major problems in dermatology. Vol. 4. London: WB Saunders, 1975 Alexander J.O. Dermatitis herpetiformis: major problems in dermatology. Vol. 4. London: WB Saunders, 1975
21.
Zurück zum Zitat Chorzelski T.P., Jablonska S., Maciejowska E. Linear IgA bullous dermatosis of adults. Clin Dermatol 1992; 9: 383–392CrossRef Chorzelski T.P., Jablonska S., Maciejowska E. Linear IgA bullous dermatosis of adults. Clin Dermatol 1992; 9: 383–392CrossRef
22.
Zurück zum Zitat Logan R.F.A., Tucker G., Rifkind E.A., et al. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960–1979. BMJ 1983; 286: 95–97PubMedCrossRef Logan R.F.A., Tucker G., Rifkind E.A., et al. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960–1979. BMJ 1983; 286: 95–97PubMedCrossRef
23.
Zurück zum Zitat Reunala T., Kosnai I., Karpati S., et al. Dermatitis herpetiformis: jejunal findings and skin response to gluten-free diet. Arch Dis Child 1984; 59: 517–522PubMedCrossRef Reunala T., Kosnai I., Karpati S., et al. Dermatitis herpetiformis: jejunal findings and skin response to gluten-free diet. Arch Dis Child 1984; 59: 517–522PubMedCrossRef
24.
Zurück zum Zitat Dieterich W., Ehnis T., Bauer M., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797–801PubMedCrossRef Dieterich W., Ehnis T., Bauer M., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797–801PubMedCrossRef
25.
Zurück zum Zitat Lundin K.E.A., Scott H., Hansen T., et al. Gliadin-specific, HLA-DQ (a1*0501, ß1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 87–96CrossRef Lundin K.E.A., Scott H., Hansen T., et al. Gliadin-specific, HLA-DQ (a1*0501, ß1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 87–96CrossRef
26.
Zurück zum Zitat Molberg O., McAdam S.N., Korner R., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713–717PubMedCrossRef Molberg O., McAdam S.N., Korner R., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713–717PubMedCrossRef
27.
Zurück zum Zitat Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234–242PubMedCrossRef Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234–242PubMedCrossRef
28.
Zurück zum Zitat Aeschlimann D., Koeller M.K., Allen-Hoffmann B.L., et al. Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. J Biol Chem 1998; 273: 3452–3460PubMedCrossRef Aeschlimann D., Koeller M.K., Allen-Hoffmann B.L., et al. Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. J Biol Chem 1998; 273: 3452–3460PubMedCrossRef
29.
Zurück zum Zitat Raghunath M., Höpfner B., Aeschlimann D., et al. Cross-linking of the dermoepidermal junction of skin regenerating from keratinocyte aurografts. J Clin Invest 1996; 98: 1174–1184PubMedCrossRef Raghunath M., Höpfner B., Aeschlimann D., et al. Cross-linking of the dermoepidermal junction of skin regenerating from keratinocyte aurografts. J Clin Invest 1996; 98: 1174–1184PubMedCrossRef
30.
Zurück zum Zitat Sárdy M., Kárpáti S., Merkl B., et al. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002; 195: 747–757PubMedCrossRef Sárdy M., Kárpáti S., Merkl B., et al. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002; 195: 747–757PubMedCrossRef
31.
Zurück zum Zitat Vogelsang H., Genser D., Wyatt J., et al. Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol 1995; 90: 394–398PubMed Vogelsang H., Genser D., Wyatt J., et al. Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol 1995; 90: 394–398PubMed
32.
Zurück zum Zitat Sulkanen S., Collin P., Laurila K., et al. IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol 1998; 33: 251–254PubMedCrossRef Sulkanen S., Collin P., Laurila K., et al. IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol 1998; 33: 251–254PubMedCrossRef
33.
Zurück zum Zitat Ladinser B., Rossipal E., Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776–778PubMedCrossRef Ladinser B., Rossipal E., Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776–778PubMedCrossRef
34.
Zurück zum Zitat Dieterich W., Laag E., Schopper H., et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317–1321PubMedCrossRef Dieterich W., Laag E., Schopper H., et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317–1321PubMedCrossRef
35.
Zurück zum Zitat Sulkanen S., Halttunen T., Laurila K., et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322–1328PubMedCrossRef Sulkanen S., Halttunen T., Laurila K., et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322–1328PubMedCrossRef
36.
Zurück zum Zitat Collin P., Mäki M., Keyriläinen O., et al. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol 1992; 27: 367–371PubMedCrossRef Collin P., Mäki M., Keyriläinen O., et al. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol 1992; 27: 367–371PubMedCrossRef
37.
Zurück zum Zitat Dieterich W., Laag E., Bruckner-Tuderman L., et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 1999; 113: 133–136PubMedCrossRef Dieterich W., Laag E., Bruckner-Tuderman L., et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 1999; 113: 133–136PubMedCrossRef
38.
Zurück zum Zitat Koop I., Ilchmann R., Izzi L., et al. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol 2000; 95: 2009–2014PubMedCrossRef Koop I., Ilchmann R., Izzi L., et al. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol 2000; 95: 2009–2014PubMedCrossRef
39.
Zurück zum Zitat Aine L. Permanent tooth dental enamel defects leading to the diagnosis of coeliac disease. Br Dent J 1994; 177: 253–254PubMedCrossRef Aine L. Permanent tooth dental enamel defects leading to the diagnosis of coeliac disease. Br Dent J 1994; 177: 253–254PubMedCrossRef
40.
Zurück zum Zitat Ballinger A., Hughes C., Kumar P., et al. Dental enamel defects in coeliac disease. Lancet 1994; 343: 230–231PubMedCrossRef Ballinger A., Hughes C., Kumar P., et al. Dental enamel defects in coeliac disease. Lancet 1994; 343: 230–231PubMedCrossRef
42.
Zurück zum Zitat Hadjivassiliou M., Grunewald R.A., Chattopadhyay A.K., et al. Clinical, radiological, neuropscyhological, and neuropathological characteristics of gluten ataxia. Lancet 1998; 352: 1582–1585PubMedCrossRef Hadjivassiliou M., Grunewald R.A., Chattopadhyay A.K., et al. Clinical, radiological, neuropscyhological, and neuropathological characteristics of gluten ataxia. Lancet 1998; 352: 1582–1585PubMedCrossRef
43.
Zurück zum Zitat Valdimarsson T., Toss G., Ross I., et al. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457–461PubMedCrossRef Valdimarsson T., Toss G., Ross I., et al. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457–461PubMedCrossRef
44.
Zurück zum Zitat Mora S., Barera G., Beccio S., et al. Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients. Am J Gastroenterol 1999; 94: 398–403PubMedCrossRef Mora S., Barera G., Beccio S., et al. Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients. Am J Gastroenterol 1999; 94: 398–403PubMedCrossRef
45.
Zurück zum Zitat Marsh M.N. Bone disease and gluten sensitivity: time to act, to treat, and to prevent. Am J Gastroenterol 1994; 89: 2105–2107PubMed Marsh M.N. Bone disease and gluten sensitivity: time to act, to treat, and to prevent. Am J Gastroenterol 1994; 89: 2105–2107PubMed
46.
Zurück zum Zitat Reunala T., Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol 1997; 136: 315–318PubMedCrossRef Reunala T., Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol 1997; 136: 315–318PubMedCrossRef
47.
Zurück zum Zitat Zettinig G., Weissel M., Flores J., et al. Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto’s thyroiditis. Eur J Clin Invest 2000; 30: 53–57PubMedCrossRef Zettinig G., Weissel M., Flores J., et al. Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto’s thyroiditis. Eur J Clin Invest 2000; 30: 53–57PubMedCrossRef
48.
Zurück zum Zitat Cunningham M.J., Zone J.J. Thyroid abnormalities in dermatitis herpetiformis. Ann Intern Med 1985; 102: 194–196PubMed Cunningham M.J., Zone J.J. Thyroid abnormalities in dermatitis herpetiformis. Ann Intern Med 1985; 102: 194–196PubMed
49.
Zurück zum Zitat Weetman A.P., Burrin J.M., Mackay D., et al. The prevalence of thyroid autoantibodies in dermatitis herpetiformis. Br J Dermatol 1988; 118: 377–383PubMedCrossRef Weetman A.P., Burrin J.M., Mackay D., et al. The prevalence of thyroid autoantibodies in dermatitis herpetiformis. Br J Dermatol 1988; 118: 377–383PubMedCrossRef
50.
Zurück zum Zitat Gaspari A.A., Huang C.-M., Davey R.J., et al. Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. Am J Med 1990; 88: 145–150PubMedCrossRef Gaspari A.A., Huang C.-M., Davey R.J., et al. Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. Am J Med 1990; 88: 145–150PubMedCrossRef
51.
Zurück zum Zitat Collin P., Kaukinen K., Välimäki M., et al. Endocrinological disorders and celiac disease. Endocr Rev 2002; 23: 464–483PubMedCrossRef Collin P., Kaukinen K., Välimäki M., et al. Endocrinological disorders and celiac disease. Endocr Rev 2002; 23: 464–483PubMedCrossRef
52.
Zurück zum Zitat Fry L., Seah P.P., Riches D.J., et al. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet 1973; I: 288–291CrossRef Fry L., Seah P.P., Riches D.J., et al. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet 1973; I: 288–291CrossRef
53.
Zurück zum Zitat Reunala T., Blomqvist K., Tarpila S., et al. Gluten-free diet in dermatitis herpetiformis: I. clinical response of skin lesions in 81 patients. Br J Dermatol 1977; 97: 473–480PubMedCrossRef Reunala T., Blomqvist K., Tarpila S., et al. Gluten-free diet in dermatitis herpetiformis: I. clinical response of skin lesions in 81 patients. Br J Dermatol 1977; 97: 473–480PubMedCrossRef
54.
Zurück zum Zitat Garioch J.J., Lewis H.M., Sargent S.A., et al. 25 years experience of a gluten-free diet in the treatment of dermatitis herpetiformis. Br J Dermatol 1994; 131: 541–545PubMedCrossRef Garioch J.J., Lewis H.M., Sargent S.A., et al. 25 years experience of a gluten-free diet in the treatment of dermatitis herpetiformis. Br J Dermatol 1994; 131: 541–545PubMedCrossRef
55.
Zurück zum Zitat Janatuinen E.K., Pikkarainen P.H., Kemppainen T.A., et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995; 333: 1033–1037PubMedCrossRef Janatuinen E.K., Pikkarainen P.H., Kemppainen T.A., et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995; 333: 1033–1037PubMedCrossRef
56.
Zurück zum Zitat Hardman C.M., Garioch J.J., Leonard J.N., et al. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1997; 337: 1884–1887PubMedCrossRef Hardman C.M., Garioch J.J., Leonard J.N., et al. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1997; 337: 1884–1887PubMedCrossRef
57.
Zurück zum Zitat Reunala T., Collin P., Holm K., et al. Tolerance to oats in dermatitis herpetiformis. Gut 1998; 43: 490–493PubMedCrossRef Reunala T., Collin P., Holm K., et al. Tolerance to oats in dermatitis herpetiformis. Gut 1998; 43: 490–493PubMedCrossRef
58.
Zurück zum Zitat Leonard J.N., Fry L. Treatment and management of dermatitis herpetiformis. Clin Dermatol 1992; 9: 403–408CrossRef Leonard J.N., Fry L. Treatment and management of dermatitis herpetiformis. Clin Dermatol 1992; 9: 403–408CrossRef
59.
Zurück zum Zitat Collin P., Pukkala E., Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 1996; 38: 528–530PubMedCrossRef Collin P., Pukkala E., Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 1996; 38: 528–530PubMedCrossRef
60.
Zurück zum Zitat Leonard J.N., Tucker W.F., Fry J.S., et al. Increased incidence of malignancy in dermatitis herpetiformis. BMJ 1983; 286: 16–18PubMedCrossRef Leonard J.N., Tucker W.F., Fry J.S., et al. Increased incidence of malignancy in dermatitis herpetiformis. BMJ 1983; 286: 16–18PubMedCrossRef
61.
Zurück zum Zitat Lewis H.M., Reunala T.L., Garioch J.J., et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996; 135: 363–367PubMedCrossRef Lewis H.M., Reunala T.L., Garioch J.J., et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996; 135: 363–367PubMedCrossRef
62.
Zurück zum Zitat Marsden R.A. The treatment of benign bullous dermatosis of childhood, and dermatitis herpetiformis and bullous pemphigoid beginning in childhood. Clin Exp Dermatol 1982; 7 (6): 653–663PubMedCrossRef Marsden R.A. The treatment of benign bullous dermatosis of childhood, and dermatitis herpetiformis and bullous pemphigoid beginning in childhood. Clin Exp Dermatol 1982; 7 (6): 653–663PubMedCrossRef
63.
Zurück zum Zitat Prussick R., Ali M.A.M., Rosenthal D., et al. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis. Arch Dermatol 1992; 128: 210–213PubMedCrossRef Prussick R., Ali M.A.M., Rosenthal D., et al. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis. Arch Dermatol 1992; 128: 210–213PubMedCrossRef
64.
Zurück zum Zitat Hörnsten P., Keisu M., Wiholm B.-E. The incidence of agranulosytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988. Arch Dermatol 1990; 126: 919–922PubMedCrossRef Hörnsten P., Keisu M., Wiholm B.-E. The incidence of agranulosytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988. Arch Dermatol 1990; 126: 919–922PubMedCrossRef
65.
Zurück zum Zitat Coleman M.D. Dapsone mediated agranulocytosis: risks, possible mechanism and prevention. Toxicology 2001; 162: 53–60PubMedCrossRef Coleman M.D. Dapsone mediated agranulocytosis: risks, possible mechanism and prevention. Toxicology 2001; 162: 53–60PubMedCrossRef
66.
Zurück zum Zitat Kastrup W., Mobacken H., Stockbrugger R., et al. Malbabsorption of vitamin B12 in dermatitis herpetiformis and its association with pernicious anemia. Acta Med Scand 1986; 220: 261–268PubMedCrossRef Kastrup W., Mobacken H., Stockbrugger R., et al. Malbabsorption of vitamin B12 in dermatitis herpetiformis and its association with pernicious anemia. Acta Med Scand 1986; 220: 261–268PubMedCrossRef
67.
Zurück zum Zitat Reunala T., Chorzelski T.P., Viander M., et al. IgA anti-endomysial antibodies in dermatitis herpetiformis: correlation with jejunal morphology, gluten-free diet and antigliadin antibodies. Br J Dermatol 1987; 117: 185–191PubMedCrossRef Reunala T., Chorzelski T.P., Viander M., et al. IgA anti-endomysial antibodies in dermatitis herpetiformis: correlation with jejunal morphology, gluten-free diet and antigliadin antibodies. Br J Dermatol 1987; 117: 185–191PubMedCrossRef
68.
Zurück zum Zitat Ventura A., Magazzu G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999; 117: 297–303PubMedCrossRef Ventura A., Magazzu G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999; 117: 297–303PubMedCrossRef
69.
Zurück zum Zitat Ferguson R., Basu M.K., Asquith P., et al. Jejunal mucosal abnormalities in patients with recurrent aphthous ulceration. BMJ 1976; 1: 11–13PubMedCrossRef Ferguson R., Basu M.K., Asquith P., et al. Jejunal mucosal abnormalities in patients with recurrent aphthous ulceration. BMJ 1976; 1: 11–13PubMedCrossRef
70.
Zurück zum Zitat Ferguson M.M., Wray D., Carmichael H.A., et al. Coeliac disease associated with recurrent aphthae. Gut 1980; 21: 223–226PubMedCrossRef Ferguson M.M., Wray D., Carmichael H.A., et al. Coeliac disease associated with recurrent aphthae. Gut 1980; 21: 223–226PubMedCrossRef
71.
72.
Zurück zum Zitat Jokinen J., Peters U., Mäki M., et al. Celiac sprue in patients with chronic oral mucosal symptoms. J Clin Gastroenterol 1998; 26: 23–26PubMedCrossRef Jokinen J., Peters U., Mäki M., et al. Celiac sprue in patients with chronic oral mucosal symptoms. J Clin Gastroenterol 1998; 26: 23–26PubMedCrossRef
73.
Zurück zum Zitat Corazza G.R., Andreani M.L., Venturo N., et al. Celiac disease and alopecia areata: report of a new association. Gastroenterology 1995; 109: 1333–1337PubMedCrossRef Corazza G.R., Andreani M.L., Venturo N., et al. Celiac disease and alopecia areata: report of a new association. Gastroenterology 1995; 109: 1333–1337PubMedCrossRef
74.
Zurück zum Zitat Volta U., Bardazzi F., Zauli D., et al. Serological screening for coeliac disease in vitiligo and alopecia areata. Br J Dermatol 1997; 136: 801–802PubMedCrossRef Volta U., Bardazzi F., Zauli D., et al. Serological screening for coeliac disease in vitiligo and alopecia areata. Br J Dermatol 1997; 136: 801–802PubMedCrossRef
75.
Zurück zum Zitat Amato L., Gallerani I., Fuligini A., et al. Dermatitis herpetiformis and vitiligo: report a case and review of literature. J Dermatol 2002; 27: 462–466 Amato L., Gallerani I., Fuligini A., et al. Dermatitis herpetiformis and vitiligo: report a case and review of literature. J Dermatol 2002; 27: 462–466
76.
Zurück zum Zitat de Vos R.J., de Boer W.A., Haas F.D. Is there a relationship between psoriasis and coeliac disease [letter]? J Intern Med 1995; 237: 118PubMedCrossRef de Vos R.J., de Boer W.A., Haas F.D. Is there a relationship between psoriasis and coeliac disease [letter]? J Intern Med 1995; 237: 118PubMedCrossRef
77.
Zurück zum Zitat Lindqvist U., Rudsander 0.A., Bostrom 0.A., et al. IgA antibodies to gliadin and coeliac disease in psoriatic atrhritis. Rheumatology 2002; 41: 31–37PubMedCrossRef Lindqvist U., Rudsander 0.A., Bostrom 0.A., et al. IgA antibodies to gliadin and coeliac disease in psoriatic atrhritis. Rheumatology 2002; 41: 31–37PubMedCrossRef
Metadaten
Titel
Recognition and Management of the Cutaneous Manifestations of Celiac Disease
A Guide for Dermatologists
verfasst von
Dr Pekka Collin
Timo Reunala
Publikationsdatum
01.01.2003
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 1/2003
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200304010-00002

Weitere Artikel der Ausgabe 1/2003

American Journal of Clinical Dermatology 1/2003 Zur Ausgabe

Adis Drug Evaluation

Terbinafine

Practical Dermatology

Drug-Induced Nail Abnormalities

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.